144 related articles for article (PubMed ID: 24907531)
1. The activity of a novel mithramycin analog is related to its binding to DNA, cellular accumulation, and inhibition of Sp1-driven gene transcription.
Fernández-Guizán A; Mansilla S; Barceló F; Vizcaíno C; Núñez LE; Morís F; González S; Portugal J
Chem Biol Interact; 2014 Aug; 219():123-32. PubMed ID: 24907531
[TBL] [Abstract][Full Text] [Related]
2. Pleiotropic Anti-Angiogenic and Anti-Oncogenic Activities of the Novel Mithralog Demycarosyl-3D-ß-D-Digitoxosyl-Mithramycin SK (EC-8042).
Fernández-Guizán A; López-Soto A; Acebes-Huerta A; Huergo-Zapico L; Villa-Álvarez M; Núñez LE; Morís F; Gonzalez S
PLoS One; 2015; 10(11):e0140786. PubMed ID: 26536461
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide modulation of gene transcription in ovarian carcinoma cells by a new mithramycin analogue.
Vizcaíno C; Núñez LE; Morís F; Portugal J
PLoS One; 2014; 9(8):e104687. PubMed ID: 25110883
[TBL] [Abstract][Full Text] [Related]
4. Novel mithramycins abrogate the involvement of protein factors in the transcription of cell cycle control genes.
Vizcaíno C; Mansilla S; Núñez LE; Méndez C; Salas JA; Morís F; Portugal J
Biochem Pharmacol; 2012 Nov; 84(9):1133-42. PubMed ID: 22981341
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic effects of mithramycin DIG-MSK can depend on the rise of autophagy.
Vizcaíno C; Rodríguez-Sánchez MA; Núñez LE; Morís F; Portugal J
Toxicol In Vitro; 2015 Oct; 29(7):1537-44. PubMed ID: 26079942
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Sp1-dependent transcription and antitumor activity of the new aureolic acid analogues mithramycin SDK and SK in human ovarian cancer xenografts.
Previdi S; Malek A; Albertini V; Riva C; Capella C; Broggini M; Carbone GM; Rohr J; Catapano CV
Gynecol Oncol; 2010 Aug; 118(2):182-8. PubMed ID: 20452660
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of p53-mediated transcriptional responses by mithramycin A.
Koutsodontis G; Kardassis D
Oncogene; 2004 Dec; 23(57):9190-200. PubMed ID: 15489892
[TBL] [Abstract][Full Text] [Related]
8. Entropically-driven binding of mithramycin in the minor groove of C/G-rich DNA sequences.
Barceló F; Scotta C; Ortiz-Lombardía M; Méndez C; Salas JA; Portugal J
Nucleic Acids Res; 2007; 35(7):2215-26. PubMed ID: 17369273
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional regulation of the human DNA methyltransferase 3A and 3B genes by Sp3 and Sp1 zinc finger proteins.
Jinawath A; Miyake S; Yanagisawa Y; Akiyama Y; Yuasa Y
Biochem J; 2005 Jan; 385(Pt 2):557-64. PubMed ID: 15362956
[TBL] [Abstract][Full Text] [Related]
10. Differential inhibition of restriction enzyme cleavage by chromophore-modified analogues of the antitumour antibiotics mithramycin and chromomycin reveals structure-activity relationships.
Mansilla S; Garcia-Ferrer I; Méndez C; Salas JA; Portugal J
Biochem Pharmacol; 2010 May; 79(10):1418-27. PubMed ID: 20093108
[TBL] [Abstract][Full Text] [Related]
11. Sp1 and Sp3 transcription factors upregulate the proximal promoter of the human prostate-specific antigen gene in prostate cancer cells.
Shin T; Sumiyoshi H; Matsuo N; Satoh F; Nomura Y; Mimata H; Yoshioka H
Arch Biochem Biophys; 2005 Mar; 435(2):291-302. PubMed ID: 15708372
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of SP1 by the mithramycin analog EC-8042 efficiently targets tumor initiating cells in sarcoma.
Tornin J; Martinez-Cruzado L; Santos L; Rodriguez A; Núñez LE; Oro P; Hermosilla MA; Allonca E; Fernández-García MT; Astudillo A; Suarez C; Morís F; Rodriguez R
Oncotarget; 2016 May; 7(21):30935-50. PubMed ID: 27105533
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of c-src transcription by mithramycin: structure-activity relationships of biosynthetically produced mithramycin analogues using the c-src promoter as target.
Remsing LL; Bahadori HR; Carbone GM; McGuffie EM; Catapano CV; Rohr J
Biochemistry; 2003 Jul; 42(27):8313-24. PubMed ID: 12846580
[TBL] [Abstract][Full Text] [Related]
14. Novel GC-rich DNA-binding compound produced by a genetically engineered mutant of the mithramycin producer Streptomyces argillaceus exhibits improved transcriptional repressor activity: implications for cancer therapy.
Albertini V; Jain A; Vignati S; Napoli S; Rinaldi A; Kwee I; Nur-e-Alam M; Bergant J; Bertoni F; Carbone GM; Rohr J; Catapano CV
Nucleic Acids Res; 2006; 34(6):1721-34. PubMed ID: 16571899
[TBL] [Abstract][Full Text] [Related]
15. Sp1 and Sp3 regulate basal transcription of the survivin gene.
Xu R; Zhang P; Huang J; Ge S; Lu J; Qian G
Biochem Biophys Res Commun; 2007 Apr; 356(1):286-92. PubMed ID: 17350596
[TBL] [Abstract][Full Text] [Related]
16. Modulation of the activity of Sp transcription factors by mithramycin analogues as a new strategy for treatment of metastatic prostate cancer.
Malek A; Núñez LE; Magistri M; Brambilla L; Jovic S; Carbone GM; Morís F; Catapano CV
PLoS One; 2012; 7(4):e35130. PubMed ID: 22545098
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic inhibition of Sp1 expression in growing tumors by mithramycin a correlates directly with potent antiangiogenic effects on human pancreatic cancer.
Yuan P; Wang L; Wei D; Zhang J; Jia Z; Li Q; Le X; Wang H; Yao J; Xie K
Cancer; 2007 Dec; 110(12):2682-90. PubMed ID: 17973266
[TBL] [Abstract][Full Text] [Related]
18. Structure of the human 5-HT7 receptor gene and characterization of its promoter region.
Laenen K; Haegeman G; Vanhoenacker P
Gene; 2007 Apr; 391(1-2):252-63. PubMed ID: 17321075
[TBL] [Abstract][Full Text] [Related]
19. Reversion of transcriptional repression of Sp1 by 5 aza-2' deoxycytidine restores TGF-beta type II receptor expression in the pancreatic cancer cell line MIA PaCa-2.
Venkatasubbarao K; Ammanamanchi S; Brattain MG; Mimari D; Freeman JW
Cancer Res; 2001 Aug; 61(16):6239-47. PubMed ID: 11507078
[TBL] [Abstract][Full Text] [Related]
20. Mithramycin A Enhances Tumor Sensitivity to Mitotic Catastrophe Resulting From DNA Damage.
Scroggins BT; Burkeen J; White AO; Chung EJ; Wei D; Chung SI; Valle LF; Patil SS; McKay-Corkum G; Hudak KE; Linehan WM; Citrin DE
Int J Radiat Oncol Biol Phys; 2018 Feb; 100(2):344-352. PubMed ID: 29157749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
